Andrew Reardon

CLO Andrew Reardon sells 5,000 shares at blended avg $227.06 via scheduled 10b5-1 plan; retains 41,382 shares plus 39,444 option shares.

Andrew Reardon, CLO & Secretary, executed 7 separate sales totaling 5,000 shares for $1,135,315.57 on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-24, indicating this transaction was scheduled rather than discretionary. The insider retains 41,382 non-derivative shares post-sale, plus 39,444 shares in unexercised stock options, so the overall position remains materially intact. LGND's fundamentals show revenue growth of 60.4% year-over-year alongside a net loss of $13,345,000 in the latest quarter, suggesting the company is in a growth-but-not-yet-profitable phase. His prior 5 sales at LGND showed mixed near-term outcomes (30-day and 90-day returns ranging from -0.9% to +2.0%), offering no clear pattern of well-timed exits specific to this ticker. As a scheduled execution within his plan rather than a discretionary decision, this sale should not be interpreted as a timing call by the insider.

CLO Andrew Reardon sells 5,000 shares at $231.31 avg price via 10b5-1 plan; holds 41,382 shares post-sale

Andrew Reardon, CLO & Secretary, executed 7 separate sales totaling 5,000 shares for $1,156,555.60 on 2026-05-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-24. The current stock price of $218.98 is -11.5% from the 52-week high of $247.38 and -5.8% over the trailing 30 days, though +19.1% over 90 days. Reardon retains 41,382 shares post-transaction, representing a -10.8% reduction from his prior 46,382 share position. Because this sale is part of a scheduled 10b5-1 plan rather than a discretionary trade, the timing reflects a pre-established execution schedule rather than a current market or operational signal.

CLO Reardon sells 5,000 LGND shares at $198.85–$204.50 for $1.0M on 2026-04-01

Reardon Andrew, CLO & Secretary, executed 6 separate sales totaling 5,000 shares for $1,006,224.10 at prices ranging from $198.85 to $204.50, reducing his holdings by 10.8% to 41,382 shares post-transaction. The current stock price of $199.59 sits 9.8% below the 52-week high of $221.24, and his cross-ticker track record shows 12 prior sells with a 90-day well-timed rate of 0.00%, indicating historically poor timing on exit decisions. LGND fundamentals remain robust with net income of $117,273,000.00 exceeding revenue of $115,461,000.00 in the latest quarter and annual revenue growth of +60.4%, yet the insider's recent prior sales at this ticker (5 trades on 2026-03-04, outcomes not yet measurable) combined with this substantial multi-tranche liquidation warrant monitoring of whether liquidity needs or valuation concerns are driving executive disposition patterns.

CLO Andrew Reardon sold 5,000 shares at blended avg $206.35 on 2026-03-04; post-sale holdings 36,869 shares.

Andrew Reardon, CLO & Secretary, executed 11 separate sales totaling 5,000 shares for $1,031,770.27 on 2026-03-04 at prices ranging from $197.70 to $208.12, with a blended average price of $206.35. This represents an 11.9% reduction in his holdings, from 41,869 to 36,869 shares. At LGND, his prior sell on 2024-05-09 was followed by a 90-day return of +12.4%, indicating that sale was poorly timed relative to subsequent price appreciation. The current stock price of $201.90 is 3.5% below the 52-week high of $209.29, and his transaction prices were at or near recent peak levels, occurring within 2.4% of the 52-week high. The company shows strong financial momentum: revenue of $115.5M in the latest quarter, net income of $117.3M, 60.4% annual revenue growth, and a P/E of 22.74.